Comment on: "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0"

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 7, 2010, Pages 1430-1431

  Saboury, Babak ^a   Torigian, Drew A ^a   Alavi, Abass ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

ATHEROSCLEROSIS; CLINICAL PRACTICE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FATTY LIVER; GLYCOLYSIS; IMAGE ANALYSIS; IMAGE PROCESSING; LESIONS AND DEFECTS; LETTER; NEOPLASM; NEUROLOGIC DISEASE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; TREATMENT RESPONSE; TUMOR DIAGNOSIS; DIAGNOSTIC USE; EUROPE; HUMAN; NUCLEAR MEDICINE; PROCEDURES; RADIOGRAPHY; SCINTISCANNING;

EUROPE; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954955123     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1458-5     Document Type: Letter

References (9)

1. Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2009;37:181-200. doi:10.1007/s00259-009-1297-4.
2. Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ, et al. Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 1987;28:431-7.
3. Zaidi H, Ruest T, Schoenahl F, Montandon ML. Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. Neuroimage 2006;32:1591-607. doi:10.1016/j.neuroimage. 2006.05.031. (Pubitemid 44332287)
4. Basu S, Zaidi H, Houseni M, Bural G, Udupa J, Acton P, et al. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Semin Nucl Med 2007;37:223-39. doi:10.1053/j.semnuclmed. 2007.01.005. (Pubitemid 46533824)
5. Alavi A, Newberg AB, Souder E, Berlin JA. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993;34:1681-7. An authors' reply to this letter is available at http://dx.doi.org/10.1007/s00259-010-1459-4
6. Berkowitz A, Basu S, Srinivas S, Sankaran S, Schuster S, Alavi A. Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET. Nucl Med Commun 2008;29:521-6. doi:10.1097/MNM.0b013e3282f813a4. (Pubitemid 351643419)
7. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-71. doi:10.1016/S1095-0397 (99) 00016-3.
8. Bural GG, Torigian DA, Chamroonrat W, Alkhawaldeh K, Houseni M, El-Haddad G, et al. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. Nucl Med Biol 2006;33:1037-43. doi:10.1016/j.nucmedbio.2006.08.005. (Pubitemid 44791952)
9. Bural GG, Torigian DA, Burke A, Houseni M, Alkhawaldeh K, Cucchiara A, et al. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imaging Biol 2009. doi:10.1007/s11307-009-0258- 4.